Lipocine Signs Supply and Distribution Deal with Pharmalink to Commercialize TLANDO
Under the terms of the agreement, Lipocine received an upfront payment from Pharmalink and, upon Marketing Authorizations (MA) in individual GCC countries, Lipocine will provide TLANDO drug products to Pharmalink at an agreed transfer price.
Pharmalink | 11/10/2024 | By Aishwarya | 268
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy